Boston Scientific Corp
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.47 | 0.65 | 0.11 | 0.55 | 0.67 | 0.98 | 0.36 | 0.86 | 0.90 | 0.91 | 0.23 | 0.99 | 3.05 | |
| 0.20 | 0.21 | 0.21 | 0.21 | 0.43 | 0.23 | 0.22 | 0.23 | 0.23 | 0.24 | 0.23 | 0.24 | 0.95 | |
| 0.04 | 0.04 | 0.04 | 0.13 | -0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.06 | 0.22 | |
| 0.05 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.12 | -0.04 | -0.50 | -0.14 | 0.11 | 0.22 | -0.45 | 0.16 | 0.03 | 0.10 | -0.61 | 0.05 | -0.43 | |
| 0.14 | 0.18 | 0.17 | 0.10 | 0.20 | 0.20 | 0.13 | 0.13 | 0.12 | 0.23 | 0.12 | 0.13 | 0.61 | |
| -0.13 | -0.71 | -0.19 | -0.18 | -0.96 | -2.49 | -0.33 | -0.75 | -0.34 | -0.34 | -0.40 | -1.32 | -2.40 | |
| 0.02 | 0.01 | 0.00 | 0.00 | 0.02 | 0.00 | – | – | – | – | – | – | – | |
| 0.11 | 0.08 | 0.05 | – | -0.04 | 0.15 | 0.08 | 0.10 | 0.18 | 0.19 | – | -1.35 | – | |
| -0.03 | – | – | – | 0.00 | 0.13 | 0.17 | -0.21 | -0.14 | -0.14 | -0.17 | 1.12 | 0.66 | |
| 0.01 | 0.01 | 1.06 | 0.02 | 0.00 | 0.14 | 0.16 | -0.23 | -0.07 | -0.12 | -0.17 | -0.28 | -0.65 | |
| 0.35 | -0.05 | 0.97 | 0.38 | -0.28 | -1.37 | 0.21 | -0.12 | 0.49 | 0.45 | -0.35 | -0.60 | -0.01 | |
| 0.33 | 0.47 | -0.05 | 0.44 | 0.47 | 0.78 | 0.24 | 0.73 | 0.78 | 0.68 | 0.11 | 0.86 | 2.44 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.